Mark Kelly, business development manager for the Separation and Purification Sciences division at 3M Ireland, reflects on some of the challenges facing the biotechnology industry, and explains how the science-based technology company is rising to them.
The biopharmaceutical industry is always striving to make process improvements, which come in many forms. Recent improvements in the upstream process have led to higher product concentrations, which are associated with higher cell densities.